scholarly article | Q13442814 |
P50 | author | Petr Novak | Q58827926 |
P2093 | author name string | Bernard W Futscher | |
Marc M Oshiro | |||
Ryan J Wozniak | |||
Walter T Klimecki | |||
Christina Kim | |||
George S Watts | |||
Marcella Nouzova | |||
Taylor Jensen | |||
P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
Compromised HOXA5 function can limit p53 expression in human breast tumours | Q22254441 | ||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 10664-10670 | |
P577 | publication date | 2006-11-06 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Epigenetic inactivation of the HOXA gene cluster in breast cancer | |
P478 | volume | 66 |
Q37600907 | A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma |
Q34462001 | A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression |
Q36871625 | Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis |
Q36402756 | Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation |
Q37187180 | Agglomerative epigenetic aberrations are a common event in human breast cancer |
Q38967805 | Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling. |
Q37440422 | Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells |
Q38931043 | BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence |
Q34533607 | Cell-type specific DNA methylation patterns define human breast cellular identity |
Q34680105 | Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity |
Q36740151 | Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing |
Q83528971 | DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis |
Q33372943 | DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage |
Q48017834 | DNA methylation of extracellular matrix remodeling genes in children exposed to arsenic |
Q41132483 | DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables |
Q37124632 | DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status |
Q53824005 | Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis. |
Q47724736 | Effect of 2,3',4,4',5-Pentachlorobiphenyl Exposure on Endometrial Receptivity and the Methylation of HOXA10. |
Q27002968 | Epigenetic changes during cell transformation |
Q36838009 | Epigenetic remodeling during arsenical-induced malignant transformation. |
Q35953777 | Estrogen-induced chromatin decondensation and nuclear re-organization linked to regional epigenetic regulation in breast cancer |
Q33881333 | Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping |
Q24611593 | Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines |
Q38389338 | Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology |
Q24296283 | FAM83B mediates EGFR- and RAS-driven oncogenic transformation |
Q30945124 | Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor |
Q37091263 | Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers |
Q35166554 | Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer |
Q33534062 | Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing |
Q38881089 | Genome-wide association studies and epigenome-wide association studies go together in cancer control |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q43671177 | Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts |
Q33687781 | Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer |
Q36932231 | HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. |
Q60170538 | HOX gene methylation status analysis in patients with hereditary breast cancer |
Q42359419 | HOXA repression is mediated by nucleoporin Nup93 assisted by its interactors Nup188 and Nup205. |
Q37706066 | Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer |
Q35720707 | Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay |
Q36622088 | Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster |
Q33474837 | Increased microRNA activity in human cancers |
Q37205583 | Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer |
Q37722954 | Molecular epidemiology and its current clinical use in cancer management |
Q36830707 | Morphogens, morphostats, microarchitecture and malignancy |
Q39069897 | Mutual regulation of microRNAs and DNA methylation in human cancers |
Q28473971 | Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors |
Q39029997 | PRC2-independent chromatin compaction and transcriptional repression in cancer |
Q38181535 | Plakophilins in desmosomal adhesion and signaling |
Q48879785 | Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome. |
Q28477414 | Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers |
Q37487009 | Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis |
Q33771160 | Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma |
Q38910673 | SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin |
Q37229718 | Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. |
Q30659867 | Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal Cancer |
Q48002910 | Tethered Oligonucleotide-Primed Sequencing, TOP-Seq: A High-Resolution Economical Approach for DNA Epigenome Profiling |
Q37117525 | The B-type lamin is required for somatic repression of testis-specific gene clusters |
Q39658606 | The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. |
Q37772356 | The epigenetics of breast cancer |
Q38764772 | The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis. |
Q49518287 | Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer |
Q21133750 | miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer |
Q33376888 | p53 induces distinct epigenetic states at its direct target promoters |
Search more.